programme Cordia is set to become the industry's largest biotech convention in Europe for trade, investment, partnership and information exchange, says organiser
Cordia's organisers have confirmed the keynote plenary
speakers and primary conference session chairs for its first
annual convention in Vienna, 2-4 December 2003.
world-class conference, exhibition and partnering forum, Cordia
is set to become the industry's largest biotech convention
in Europe for trade, investment, partnership and information
Some of the most influential figures in the life
sciences industry will open the conference with the theme
'Bringing Knowledge to Life: Europe's Life Science
Opportunity on a Global Scale'.
The keynote speakers
include: Professor Leena Peltonen, chair, Department of Molecular
Medicine, National Public Health Institute, Helsinki.
Sijbesma, chairman EuropaBio, member of the board of DSM.
Philippe Pouletty, vice-chairman EuropaBio, president France
Ysbrand Poortman, chairman, European Platform for
Patients' Organisations, Science and Industry (EPPOSI).
keynote speakers will put Europe's key assets under the
microscope from a political, scientific, social and industrial
perspective, and will present a framework for improving the
global competiveness of the European biotechnology community and
for meeting society's needs more effectively.
speakers will address the burning issues of the day.
The need for
a regulatory environment to enable the biotech industry to bring
new biomedical solutions to patients, and to foster the
industry's contribution to a sustainable economy.
to double effort and investment in bioscientific education and
research to ensure Europe fosters and retains its many talents
and attracts the best ones from abroad.
measures to stimulate the creation and growth of young innovative
"Despite Europe's excellence and initial
lead in biosciences, North America is now leading the way in
turning breakthrough discoveries into revenue generating
"One of Cordia's aims is to foster the
right environment to enable Europe's biotechnology community
to compete globally on a level playing field," said Hugo
Schepens, secretary general, EuropaBio.
"For the first time
outside North America, Cordia offers delegates and exhibitors the
opportunity to learn from and do business with some the
world's most respected names in the life sciences
industry," added Schepens.
"This is the toughest
environment the majority of European life science companies have
yet faced; the timing of Cordia as a learning and business forum
could not be more important for the sector and has been an
important motivator in developing the conference programme,"
added Helen Abbott, senior consultant at Technomark.
conference programme features some 300 speakers in 60 parallel
sessions which are divided into five streams dedicated to
addressing the catalysts and barriers to growth and innovation in
the healthcare, agriculture, industrial and environmental
Cordia's exhibition will combine national pavilions
from Europe, the USA, and Asia, with independent stands featuring
leading biotech and pharmaceutical companies, and key industry
advisors including VCs, lawyers and consultants.